This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Francesca Storici: Innovator in In Vivo Mutagenesis
Introduction
Francesca Storici is a prominent inventor based in Durham, NC (US). She has made significant contributions to the field of genetic engineering, particularly in the area of site-directed mutagenesis. Her innovative work has implications for various organisms that utilize homologous recombination systems.
Latest Patents
Francesca holds 1 patent titled "Systems for in vivo site-directed mutagenesis using oligonucleotides." This patent discloses several methods to generate nucleic acid mutations in vivo, ensuring that no heterologous sequence is retained after the mutagenesis process is complete. The methods utilize integrative recombinant oligonucleotides (IROs) and enable site-specific point mutations, deletions, and insertions. Additionally, her methods allow for multiple rounds of mutation and random mutagenesis in localized regions, showcasing their versatility across different organisms.
Career Highlights
Francesca has been recognized for her innovative approaches in genetic research. She works for the United States of America, as represented by the Secretary, Department of Health and Human Services. Her work has paved the way for advancements in genetic manipulation techniques, contributing to the broader scientific community.
Collaborations
Francesca has collaborated with notable colleagues, including Lysle Kevin Lewis and Michael A Resnick. These partnerships have enhanced her research and expanded the impact of her inventions in the field.
Conclusion
Francesca Storici's contributions to in vivo mutagenesis represent a significant advancement in genetic engineering. Her innovative methods and collaborative efforts continue to influence the scientific community and pave the way for future research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
